-
Crispr therapy is designed to attack tumors.
Researchers at the University College London have used gene editing to identify each patient’s cancer receptors and put them in immune cells without them. The edits allowed the donor T cells to slip past the body’s defenses, recognise a certain receptor on leukemia cells, and kill the cancer. The patient will receive the edited cells…